Evidence map›Paper›PMID 40682456›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2025

Spread of the FAR-MRSA clone, a fusidic acid- and meticillin-resistant

Louise Roer, Nicolas Yin, Olivier Denis, Karuna Ew Vendrik, Romy D Zwittink, Daan W Notermans, Monique Perrin, Kirstin Khonyongwa, Anne Tristan, Benjamin Youenou and 23 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. [Wound care following dermatologic surgical procedures].Dermatologie (Heidelberg, Germany) · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Louise RoerStatens Serum Institut, Copenhagen, Denmark.
Nicolas YinNational reference centre for Staphylococcus aureus and other species, Department of microbiology, Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB), Université libre de Bruxelles, Brussels, Belgium.
Olivier DenisNational reference centre for Staphylococcus aureus and other species, Department of microbiology, Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB), Université libre de Bruxelles, Brussels, Belgium.
Karuna Ew VendrikNational Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Romy D ZwittinkNational Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Daan W NotermansNational Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Monique PerrinLaboratoire National de Sante, Dudelange, Luxembourg.
Kirstin KhonyongwaLaboratoire National de Sante, Dudelange, Luxembourg.
Anne TristanCentre National de Référence des Staphylocoques, Hospices Civils de Lyon, Lyon, France.
Benjamin YouenouCentre National de Référence des Staphylocoques, Hospices Civils de Lyon, Lyon, France.
Franziska Layer-NicolaouDivision Nosocomial Pathogens and Antibiotic Resistances, Department of Infectious Diseases, National Reference Centre for Staphylococci and Enterococci, Robert Koch Institute, Wernigerode Branch, Wernigerode, Germany.
Guido WernerDivision Nosocomial Pathogens and Antibiotic Resistances, Department of Infectious Diseases, National Reference Centre for Staphylococci and Enterococci, Robert Koch Institute, Wernigerode Branch, Wernigerode, Germany.
Hege EngerThe Norwegian MRSA Reference Laboratory, Department of Medical Microbiology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Emily Charlotte Henry EikremThe Norwegian MRSA Reference Laboratory, Department of Medical Microbiology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Jessica DarenbergThe Public Health Agency of Sweden, Solna, Sweden.
Barbro MäkitaloThe Public Health Agency of Sweden, Solna, Sweden.
Magnus PaulssonMedical faculty, Lund University, Lund, Sweden.
Jonas BjörkmanRegion Skåne, Lund, Sweden.
Hong FangKarolinska University Hospital, Stockholm, Sweden.
Erika Tång HallbäckDepartment of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Martin SundqvistDepartment of Laboratory Medicine, Clinical Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Laura LindholmFinnish Institute for Health and Welfare, Helsinki, Finland.
Kartyk MoganeradjUK Health Security Agency, Colindale, England.
Silvia García-CobosLaboratorio de Referencia e Investigación en Resistencia a Antibióticos e Infecciones Relacionadas con la Asistencia Sanitaria, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Javier E Cañada-GarcíaLaboratorio de Referencia e Investigación en Resistencia a Antibióticos e Infecciones Relacionadas con la Asistencia Sanitaria, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Barbara Juliane HolzknechtDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Helle Brander EriksenCopenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
Morten HoppeCopenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
Mette Damkjær BartelsCopenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark.
Jose Alfredo Samaniego CastruitaCopenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark.
Tinna Ravnholt UrthStatens Serum Institut, Copenhagen, Denmark.
Anders Rhod LarsenThese authors contributed equally to this work and share last authorship.
Andreas PetersenThese authors contributed equally to this work and share last authorship.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe the genetic characteristics of a fusidic acid- and meticillin-resistant

Indexed as

Fusidic AcidMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAdolescentAdultAgedAnti-Bacterial AgentsChildChild, PreschoolCommunity-Acquired InfectionsEuropeFemaleHumansImpetigoInfantMaleAnti-Bacterial AgentsFusidic Acidfusidic acid resistanceimpetigointernational cloneMethicillin-resistancemulti-resistanceStaphylococcus aureus

Identifiers

PMID40682456
PMCPMC12273254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.